ChartRow logo
ChartRow
Investing Charts
ABBV
AbbVie Inc.Stock · HealthcareS&P 500 0.7%
$259.22+$2.30 (+0.90%)as of market close, Jul 24, 2026
CompareLLYUNHJNJISRGABTMRK

ABBVAbbVie Inc. stock price, chart and key statistics

Key stats

Price data

Price
$259.22
Change YTD
+13.04%
Next earnings
Jul 31, 2026 · Before open
Market cap
458B
Enterprise value
513.1B
Shares outstanding
1.8B
52W low
$187.62
52W high
$261.64
From 52W high
-0.92%
From 52W low
+38.16%
52W range
97%
Beta
0.28

Volume

Rel volume
0.67×
30D volume
7.9M
30D $ vol
1.9B

Fundamentals

Sales (ttm)
62.8B
Sales/share
$35.56
EPS (ttm)
$2.03
FCF (ttm)
20B
FCF/share
$11.31
Book value/share
$-3.77
Net margin
5.79%
ROA
2.66%
Current ratio
0.80

Growth (CAGR, ttm) · 10Y

Sales
+10.20%
Net income
-4.02%
FCF
+10.19%
Shares
+0.89%

Per-share growth (CAGR, ttm) · 10Y

EPS
-4.80%
Sales/share
+9.23%
FCF/share
+9.22%
Book value/share
n/a
Dividend/share
+12.05%
Price
+15.04%
Total return
+19.70%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
126.0×
Fwd P/E
15.8×
P/S (ttm)
7.3×
P/FCF (ttm)
22.9×
EV/EBITDA (fy)
32.4×
EV/Sales (ttm)
8.2×
FCF yield (ttm)
4.36%
Dividend yield (fwd)
2.67%
Dividend/share (fwd)
$6.92
Buyback yield (ttm)
0.33%
Shareholder yield (ttm)
2.91%

Vs own 10Y history

P/E
97th
P/S
100th
P/B
97th
P/FCF
99th

Bar = where today's multiple sits in ABBV's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+0.90%
1W
+1.86%
1M
+10.36%
3M
+29.00%
YTD
+13.04%
1Y
+36.04%
5Y
+120.61%

Financial statements

Open full ABBV financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B
GILD
Gilead Sciences Inc.
Biotech$129+3.32%976.5M

AbbVie Inc. (ABBV) trades at $259.22 with a live price and an interactive chart covering 13+ years of daily price history, plus key valuation metrics. ChartRow also publishes ABBV's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ABBV financial statements →